17-10-16 ⓔ文献

  1. Luzuriaga K, Sullivan JL: Infectious mononucleosis. N Engl J Med, 2010; 362: 1993–2000.

  2. Takeuchi K, Tanaka–Taya K, et al: Prevalence of Epstein–Barr virus in Japan: trends and future prediction. Pathol Int, 2006; 56: 112–116.

  3. Hurt C, Tammaro D: Diagnostic evaluation of mononucleosis–like illnesses. Am J Med, 2007; 120: 911, e1–911, e8.

  4. He HL, Wang MC, et al: Infectious mononucleosis mimicking malignant T–cell lymphoma in the nasopharynx: a case report and review of the literature. Int J Clin Exp Pathol, 2013; 6: 105–109.

  5. Stephenson JT, DuBois JJ: Nonoperative management of spontaneous splenic rupture in infectious mononucleosis: a case report and review of the literature. Pediatrics, 2007; 120: e432–e435.

  6. Yamamoto M, Kimura H, et al: Detection and quantification of virus DNA in plasma of patients with Epstein–Barr virus–associated diseases. J Clin Microbiol, 1995; 33: 1765–1768.

  7. Quintanilla–Martinez L, Kumar S, et al: Fulminant EBV (+) T–cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood, 2000; 96: 443–451.

  8. Kimura H, Morishima T, et al: Japanese Association for Research on Epstein–Barr Virus and Related Diseases. Prognostic factors for chronic active Epstein–Barr virus infection. J Infect Dis, 2003; 187: 527–533.

  9. Balfour HH Jr, Hokanson KM, et al: A virologic pilot study of valacyclovir in infectious mononucleosis. J Clin Virol, 2007; 39: 16–21.